Frontiers in Oncology (Feb 2020)

Long Non-coding Wilms Tumor 1 Antisense RNA in the Development and Progression of Malignant Tumors

  • Ye Zhang,
  • Lin-Jun Fan,
  • Yi Zhang,
  • Jun Jiang,
  • Xiao-Wei Qi

DOI
https://doi.org/10.3389/fonc.2020.00035
Journal volume & issue
Vol. 10

Abstract

Read online

A growing number of studies have shown that long non-coding RNAs (lncRNAs) play an important role in tumor development and progression and are key molecules affecting tumor progression. The lncRNA Wilms tumor 1 antisense RNA (WT1-AS) is specifically expressed in various malignant tumors. In particular, WT1-AS expression is upregulated in colon cancer and breast cancer but is significantly downregulated in cervical cancer, liver cancer, and kidney cancer. The level of WT1-AS expression is closely related to the size, stage, and patient survival rate of these cancers. In this article, we review the modes of action, expression, function, and mechanisms of WT1-AS in different tumors to provide new targets for tumor diagnosis and treatment.

Keywords